QuickView for Methyl-CpG binding protein 2/3, C-terminal domain (biogroup)

1. Myoblasts overexpressing different isoforms of DUX4 and treated with DEF103 defensin
2. Prostate cancer LNCaP cells with conditional expression of TMPRSS2-ERG fusion variants III and VI
3. Ewing's sarcoma of bone TC71 cells with CRISPR-CAS9 mediated ID2 knockout & rescue by re-expression
4. Myoblasts WS236 15Vbic overexpressing human DUX4 or mouse DUX
5. miRNA expression In maintenance and differentiation of human embryonic stem cells

There were no matches for Methyl-CpG binding protein 2/3, C-terminal domain

There were no clinical trials for Methyl-CpG binding protein 2/3, C-terminal domain